Avio Smart Market Stack appoints Sandeep Pandya to lead global sales
Avio Smart Market Stack Limited has appointed Sandeep Pandya as Head – International Sales, Diagnostics & Healthcare Division to accelerate its global expansion strategy. Pandya brings over two decades of experience from companies like Meril Life Sciences and Beacon Diagnostics. The company aims to expand the international footprint of Huwei Lifesciences' molecular diagnostics portfolio.

*this image is generated using AI for illustrative purposes only.
Avio Smart Market Stack Limited has appointed healthcare industry veteran Sandeep Pandya as Head – International Sales, Diagnostics & Healthcare Division, to accelerate its global expansion strategy in diagnostics and healthcare technologies. The appointment underscores the company's focus on building a globally scalable business through indigenous technologies and strategic collaborations.
Pandya brings over two decades of experience across diagnostics, medical devices, pharmaceuticals, and healthcare technologies. He has previously held leadership roles at Meril Life Sciences, Beacon Diagnostics, CTX Life Sciences, and Span Diagnostics, where he led international market development, distributor networks, and regulatory initiatives.
In his new role, Pandya will spearhead bartronics 's international business development efforts. His responsibilities will include market expansion, strategic partnerships, distribution network development, and commercialisation of the company's healthcare portfolio across global markets.
A key priority for the new appointee will be expanding the international footprint of Huwei Lifesciences' molecular diagnostics portfolio. This portfolio serves as a cornerstone of Avio Stack's healthcare strategy and includes advanced solutions for tuberculosis (TB), drug-resistant TB, sepsis, HPV, hepatitis, antimicrobial resistance (AMR), and respiratory illnesses.
Vidya Sagar Reddy, Managing Director of Avio Smart Market Stack Limited, highlighted the strategic importance of the move. "Healthcare and diagnostics represent a strategic growth pillar for Avio Stack. As we continue building a globally relevant healthcare platform, strengthening our international presence becomes increasingly important," Reddy said.
The company aims to strengthen its presence across both emerging and developed healthcare markets. The long-term vision involves improving access to affordable, high-quality diagnostic solutions through expanded international market access and indigenous healthcare technologies.
How will the integration of Huwei Lifesciences' molecular diagnostics portfolio impact Avio Stack's competitive positioning in global markets?
What specific regulatory challenges might Pandya face when expanding into developed versus emerging healthcare markets?
Are there plans to form strategic partnerships with local distributors or manufacturers to accelerate market penetration?

































